Surgical Care And Recovery With Laser Evaluation Trial (SCARLET)

Starting soon · Not applicable

Conditions studied: Post-surgical Scars, Hypertrophic Scars, Scar Appearance Dissatisfaction, Aesthetic Surgical Outcomes, Wound Healing After Body-contouring Surgery

In brief

The Surgical Care and Recovery with Laser Evaluation Trial (S.C.A.R.L.E.T.) is a prospective, single-center clinical study conducted at AdventHealth Medical Group Plastic and Reconstructive Surgery at Innovation Tower. The study evaluates whether early adjuvant ProFractional laser and/or Broadband Light (BBL) therapy improves the appearance, texture, and patient-reported outcomes of surgical scars following major body-contouring procedures. Participants undergoing qualifying surgeries will be grouped as either cosmetic (receiving three laser/BBL sessions) or non-cosmetic (receiving standard care only). Scar outcomes will be assessed using validated instruments-SCAR-Q and Patient and Observer Scar Assessment Scale (POSAS)-along with standardized photographic analysis at serial follow-ups through six months postoperatively.

Key facts

Study ID

NCT07359352

Run by

AdventHealth

People needed

150

Starts

2026-04-01

Expected to finish

2027-10-01

Last updated by the study team

2026-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 18 years or older.
• Scheduled to undergo one or more of the following major body-contouring procedures during the study period:
• Brachioplasty (arm lift)
• Chest or breast contouring surgery
• Abdominoplasty or panniculectomy
• Buttock lift or lower body lift
• Thighplasty (thigh lift)
• Able and willing to provide written informed consent.
• Able to read and write in English (required for completion of validated questionnaires).
• Willing and able to comply with scheduled follow-up visits, questionnaires, and study procedures for up to 12 months post-surgery.

You may not qualify if…

• Inability or unwillingness to provide informed consent.
• Inability to comply with study visits or procedures.
• Non-English speakers, as the validated SCAR-Q and POSAS instruments are not currently available in equivalent translations.
• Current use of nicotine or nicotine-containing products, including cigarettes, vaping, chewing tobacco, or nicotine replacement therapy, due to the known adverse effects of nicotine on wound healing and scar formation.
• Any medical condition, treatment, or circumstance that, in the opinion of the Investigator, may increase participant risk, compromise safety, or interfere with study participation or data integrity.
• Pregnant or breastfeeding women (laser/BBL therapy contraindicated in pregnancy).
• History of abnormal scar formation such as keloids or hypertrophic scarring (if deemed clinically significant by the investigator).
• Recent energy-based treatment (laser, IPL, or BBL) to the surgical site within the previous 3 months.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.